Great Novel Therapeutics Biotech & Medicals (TPEX:7427)

Market Cap	1.67B
Revenue (ttm)	1.69M
Net Income (ttm)	-104.92M
Shares Out	43.64M
EPS (ttm)	-2.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,778
Average Volume	54,770
Open	38.00
Previous Close	38.15
Day's Range	37.00 - 38.85
52-Week Range	30.10 - 55.20
Beta	-0.02
RSI	50.84
Earnings Date	May 14, 2025

About TPEX:7427

Great Novel Therapeutics Biotech & Medicals engages in the development of drugs for the treatment of advanced and refractory cancers. It develops drugs for cancer immunotherapy, including tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was formerly known as GNT Biotech & Medicals Corporation. Great Novel Therapeutics Biotech & Medicals was founded in 2013 and is based in Taipei City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2013
• Employees: 18
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7427

Financial Performance

In 2024, TPEX:7427's revenue was 1.69 million, a decrease of -65.26% compared to the previous year's 4.85 million. Losses were -104.92 million, 72.0% more than in 2023.